HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 279, Issue 51, 53506-53515, December 17, 2004

This Article Full Text Full Text (PDF) Supplemental Data All Versions of this Article: 279/51/53506    most recent M401625200v1 Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lovmar, M. Articles by Ehrenberg, M. Search for Related Content PubMed PubMed Citation Articles by Lovmar, M. Articles by Ehrenberg, M. Social Bookmarking                      What's this?

Kinetics of Macrolide Action

THE JOSAMYCIN AND ERYTHROMYCIN CASES^*

Martin Lovmar, Tanel Tenson, and Måns Ehrenberg¶

From the Department of Cell and Molecular Biology, Molecular Biology Program, BMC, Box 596, Uppsala University, S-75124 Uppsala, Sweden and Institute of Technology, Tartu University, Riia 23, Tartu 51010, Estonia

Members of the macrolide class of antibiotics inhibit peptide elongation on the ribosome by binding close to the peptidyltransferase center and blocking the peptide exit tunnel in the large ribosomal subunit. We have studied the modes of action of the macrolides josamycin, with a 16-membered lactone ring, and erythromycin, with a 14-membered lactone ring, in a cell-free mRNA translation system with pure components from Escherichia coli. We have found that the average lifetime on the ribosome is 3 h for josamycin and less than 2 min for erythromycin and that the dissociation constants for josamycin and erythromycin binding to the ribosome are 5.5 and 11 nM, respectively. Josamycin slows down formation of the first peptide bond of a nascent peptide in an amino acid-dependent way and completely inhibits formation of the second or third peptide bond, depending on peptide sequence. Erythromycin allows formation of longer peptide chains before the onset of inhibition. Both drugs stimulate the rate constants for drop-off of peptidyl-tRNA from the ribosome. In the josamycin case, drop-off is much faster than drug dissociation, whereas these rate constants are comparable in the erythromycin case. Therefore, at a saturating drug concentration, synthesis of full-length proteins is completely shut down by josamycin but not by erythromycin. It is likely that the bacterio-toxic effects of the drugs are caused by a combination of inhibition of protein elongation, on the one hand, and depletion of the intracellular pools of aminoacyl-tRNAs available for protein synthesis by drop-off and incomplete peptidyl-tRNA hydrolase activity, on the other hand.

Received for publication, February 13, 2004 , and in revised form, September 21, 2004.

^* This work was supported by The Swedish Research Council, The Wellcome Trust International Senior Fellowship 070210/Z/03/Z, and Estonian Science Foundation Grant 5311. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The on-line version of this article (available at http://www.jbc.org) contains additional text.

^¶ To whom correspondence should be addressed: Dept. of Cell and Molecular Biology, Molecular Biology Program, BMC, Box 596, Uppsala University, S-75124 Uppsala, Sweden. Tel.: 46-18-471-42-13; Fax: 46-18-471-42-62; E-mail: ehrenberg{at}xray.bmc.uu.se.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				E. C. Kouvela, D. L. Kalpaxis, D. N. Wilson, and G. P. Dinos Distinct Mode of Interaction of a Novel Ketolide Antibiotic That Displays Enhanced Antimicrobial Activity Antimicrob. Agents Chemother., April 1, 2009; 53(4): 1411 - 1419. [Abstract] [Full Text] [PDF]

				T. Siibak, L. Peil, L. Xiong, A. Mankin, J. Remme, and T. Tenson Erythromycin- and Chloramphenicol-Induced Ribosomal Assembly Defects Are Secondary Effects of Protein Synthesis Inhibition Antimicrob. Agents Chemother., February 1, 2009; 53(2): 563 - 571. [Abstract] [Full Text] [PDF]

				S. D. Moore and R. T. Sauer Revisiting the mechanism of macrolide-antibiotic resistance mediated by ribosomal protein L22 PNAS, November 25, 2008; 105(47): 18261 - 18266. [Abstract] [Full Text] [PDF]

				A. D. Petropoulos, E. C. Kouvela, G. P. Dinos, and D. L. Kalpaxis Stepwise Binding of Tylosin and Erythromycin to Escherichia coli Ribosomes, Characterized by Kinetic and Footprinting Analysis J. Biol. Chem., February 22, 2008; 283(8): 4756 - 4765. [Abstract] [Full Text] [PDF]

				P. Karahalios, D. L. Kalpaxis, H. Fu, L. Katz, D. N. Wilson, and G. P. Dinos On the Mechanism of Action of 9-O-Arylalkyloxime Derivatives of 6-O-Mycaminosyltylonolide, a New Class of 16-Membered Macrolide Antibiotics Mol. Pharmacol., October 1, 2006; 70(4): 1271 - 1280. [Abstract] [Full Text] [PDF]

				A. Raine, M. Lovmar, J. Wikberg, and M. Ehrenberg Trigger Factor Binding to Ribosomes with Nascent Peptide Chains of Varying Lengths and Sequences J. Biol. Chem., September 22, 2006; 281(38): 28033 - 28038. [Abstract] [Full Text] [PDF]

				M. Lovmar, K. Nilsson, V. Vimberg, T. Tenson, M. Nervall, and M. Ehrenberg The Molecular Mechanism of Peptide-mediated Erythromycin Resistance J. Biol. Chem., March 10, 2006; 281(10): 6742 - 6750. [Abstract] [Full Text] [PDF]

				A. TSAGKALIA, F. LEONTIADOU, M. A. XAPLANTERI, G. PAPADOPOULOS, D. L. KALPAXIS, and T. CHOLI-PAPADOPOULOU Ribosomes containing mutants of L4 ribosomal protein from Thermus thermophilus display multiple defects in ribosomal functions and sensitivity against erythromycin RNA, November 1, 2005; 11(11): 1633 - 1639. [Abstract] [Full Text] [PDF]